BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230216T120000
DTEND;TZID=UTC:20230216T130000
DTSTAMP:20260603T214616
CREATED:20230208T195958Z
LAST-MODIFIED:20230208T195958Z
UID:10000357-1676548800-1676552400@ctl.cornell.edu
SUMMARY:Due Diligence on Investors - Webinar
DESCRIPTION:On Thursday\, February 16\, noon – 1 pm ET\, Weill Cornell Medicine Enterprise Innovation is hosting a virtual program to find out the types of questions founders need to ask before approaching investors\, as well as what to expect in a long-term partnership. This is the second event that will kick off the 2023 Startup Symposium & InvestConnect Conference\, scheduled for Thursday\, February 23.  \nClick HERE to RSVP for Due Diligence on Investors \n ———- \nModerator: \nLiz Hamburg\, MBA\, Founder & President\, Candoo Tech \nPanelists: \n\nRobert Ang\, MBBS\, MBA\, CEO\, Vor Bio\nSumayah Jamal\, MD-PhD\, President\, Co-founder\, CSO\, ENB Therapeutics\nKatherine Saunders\, MD\, DABOM\, Executive VP\, Senior Medical Officer\, Intellihealth
URL:https://ctl.cornell.edu/event/due-diligence-on-investors-webinar
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/02/Due-diligence-Events-page-image-size-700x500px-1.png
END:VEVENT
END:VCALENDAR